Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Malignant Lymphoma

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 82 articles:
HTML format
Text format



Single Articles


    January 2019
  1. GUO B, Tan X, Ke Q, Cen H, et al
    Prognostic value of baseline metabolic tumor volume and total lesion glycolysis in patients with lymphoma: A meta-analysis.
    PLoS One. 2019;14:e0210224.
    PubMed     Text format     Abstract available


  2. TAKASHIMA Y, Kawaguchi A, Iwadate Y, Hondoh H, et al
    MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma.
    PLoS One. 2019;14:e0210400.
    PubMed     Text format     Abstract available


  3. WANG H, Zhou LY, Guan ZB, Zeng WB, et al
    Prognostic significance of DAPK promoter methylation in lymphoma: A meta-analysis.
    PLoS One. 2019;14:e0210943.
    PubMed     Text format     Abstract available


  4. TOLEDANO MN, Vera P, Tilly H, Jardin F, et al
    Comparison of therapeutic evaluation criteria in FDG-PET/CT in patients with diffuse large-cell B-cell lymphoma: Prognostic impact of tumor/liver ratio.
    PLoS One. 2019;14:e0211649.
    PubMed     Text format     Abstract available


  5. GONZALEZ-RINCON J, Mendez M, Gomez S, Garcia JF, et al
    Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma.
    PLoS One. 2019;14:e0212813.
    PubMed     Text format     Abstract available


  6. BERZACZY D, Haug AR, Raderer M, Kiesewetter B, et al
    Is there a reliable size cut-off for splenic involvement in lymphoma? A [18F]FDG-PET controlled study.
    PLoS One. 2019;14:e0213551.
    PubMed     Text format     Abstract available


  7. LINABURG T, Davis AR, Frey NV, Khawaja MR, et al
    Hodgkin lymphoma patients have an increased incidence of idiopathic acquired aplastic anemia.
    PLoS One. 2019;14:e0215021.
    PubMed     Text format     Abstract available


  8. GIAGNUOLO G, Buffardi S, Rossi F, Petruzziello F, et al
    Single center experience on efficacy and safety of Aprepitant for preventing chemotherapy-induced nausea and vomiting (CINV) in pediatric Hodgkin Lymphoma.
    PLoS One. 2019;14:e0215295.
    PubMed     Text format     Abstract available


  9. MEI M, Wang Y, Zhang M
    Causes of mortality in cases with extra nodal natural killer/T-cell lymphoma, nasal type: A cohort study.
    PLoS One. 2019;14:e0214860.
    PubMed     Text format     Abstract available


  10. GIANNUZZI D, Marconato L, Cascione L, Comazzi S, et al
    Mutational landscape of canine B-cell lymphoma profiled at single nucleotide resolution by RNA-seq.
    PLoS One. 2019;14:e0215154.
    PubMed     Text format     Abstract available


  11. ALLCHIN RL, Kelly ME, Mamand S, Doran AG, et al
    Structural and diffusion weighted MRI demonstrates responses to ibrutinib in a mouse model of follicular helper (Tfh) T-cell lymphoma.
    PLoS One. 2019;14:e0215765.
    PubMed     Text format     Abstract available


  12. PARK HY, Hong YC, Lee K, Koh J, et al
    Vitamin D status and risk of non-Hodgkin lymphoma: An updated meta-analysis.
    PLoS One. 2019;14:e0216284.
    PubMed     Text format     Abstract available


  13. MELENOTTE C, Mezouar S, Ben Amara A, Benatti S, et al
    A transcriptional signature associated with non-Hodgkin lymphoma in the blood of patients with Q fever.
    PLoS One. 2019;14:e0217542.
    PubMed     Text format     Abstract available


    January 2018
  14. BYFORD ET, Carr M, Ladikou E, Ahearne MJ, et al
    Circulating Tfh1 (cTfh1) cell numbers and PD1 expression are elevated in low-grade B-cell non-Hodgkin's lymphoma and cTfh gene expression is perturbed in marginal zone lymphoma.
    PLoS One. 2018;13:e0190468.
    PubMed     Text format     Abstract available


  15. KANG KW, Lee SR, Kim DS, Yu ES, et al
    Lack of usefulness of computed tomography for surveillance in patients with aggressive non-Hodgkin lymphoma.
    PLoS One. 2018;13:e0192656.
    PubMed     Text format     Abstract available


  16. DE JONG MRW, Visser L, Huls G, Diepstra A, et al
    Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approach.
    PLoS One. 2018;13:e0193098.
    PubMed     Text format     Abstract available


  17. NESKA-MATUSZEWSKA M, Bladowska J, Sasiadek M, Zimny A, et al
    Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach.
    PLoS One. 2018;13:e0191341.
    PubMed     Text format     Abstract available


  18. BARISONE GA, O'Donnell RT, Ma Y, Abuhay MW, et al
    A purified, fermented, extract of Triticum aestivum has lymphomacidal activity mediated via natural killer cell activation.
    PLoS One. 2018;13:e0190860.
    PubMed     Text format     Abstract available


  19. CHIHARA D, Fanale MA, Miranda RN, Noorani M, et al
    The risk of central nervous system relapses in patients with peripheral T-cell lymphoma.
    PLoS One. 2018;13:e0191461.
    PubMed     Text format     Abstract available


  20. MENON M, Coghill A, Mutyaba I, Okuku F, et al
    Whom to treat? Factors associated with chemotherapy recommendations and outcomes among patients with NHL at the Uganda Cancer Institute.
    PLoS One. 2018;13:e0191967.
    PubMed     Text format     Abstract available


  21. WANG H, Shen G, Jiang C, Li L, et al
    Prognostic value of baseline, interim and end-of-treatment 18F-FDG PET/CT parameters in extranodal natural killer/T-cell lymphoma: A meta-analysis.
    PLoS One. 2018;13:e0194435.
    PubMed     Text format     Abstract available


  22. SHAMOON RP, Ali MD, Shabila NP
    Overview and outcome of Hodgkin's Lymphoma: Experience of a single developing country's oncology centre.
    PLoS One. 2018;13:e0195629.
    PubMed     Text format     Abstract available


  23. SHIMONO J, Miyoshi H, Kiyasu J, Kamimura T, et al
    Clinicopathological analysis of polyploid diffuse large B-cell lymphoma.
    PLoS One. 2018;13:e0194525.
    PubMed     Text format     Abstract available


  24. GARDNER HL, Rippy SB, Bear MD, Cronin KL, et al
    Phase I/II evaluation of RV1001, a novel PI3Kdelta inhibitor, in spontaneous canine lymphoma.
    PLoS One. 2018;13:e0195357.
    PubMed     Text format     Abstract available


  25. WOLFF A, Bayerlova M, Gaedcke J, Kube D, et al
    A comparative study of RNA-Seq and microarray data analysis on the two examples of rectal-cancer patients and Burkitt Lymphoma cells.
    PLoS One. 2018;13:e0197162.
    PubMed     Text format     Abstract available


  26. GAO X, Li J, Wang Y, Liu S, et al
    Clinical characteristics and prognostic significance of EBER positivity in diffuse large B-cell lymphoma: A meta-analysis.
    PLoS One. 2018;13:e0199398.
    PubMed     Text format     Abstract available


  27. MORENO MJ, Gallardo A, Novelli S, Mozos A, et al
    CXCR7 expression in diffuse large B-cell lymphoma identifies a subgroup of CXCR4+ patients with good prognosis.
    PLoS One. 2018;13:e0198789.
    PubMed     Text format     Abstract available


  28. WU CH, Yang YH, Chen MR, Tsai CH, et al
    Autocleavage of the paracaspase MALT1 at Arg-781 attenuates NF-kappaB signaling and regulates the growth of activated B-cell like diffuse large B-cell lymphoma cells.
    PLoS One. 2018;13:e0199779.
    PubMed     Text format     Abstract available


  29. MUKHTAR F, Boffetta P, Dabo B, Park JY, et al
    Disparities by race, age, and sex in the improvement of survival for lymphoma: Findings from a population-based study.
    PLoS One. 2018;13:e0199745.
    PubMed     Text format     Abstract available


  30. TAGAWA M, Kurashima C, Takagi S, Maekawa N, et al
    Evaluation of costimulatory molecules in dogs with B cell high grade lymphoma.
    PLoS One. 2018;13:e0201222.
    PubMed     Text format     Abstract available


  31. CHACHAJ A, Wisniewski J, Rybka J, Butrym A, et al
    Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study.
    PLoS One. 2018;13:e0197148.
    PubMed     Text format     Abstract available


  32. LIU F, Wang Z, Zhou X, Liu Q, et al
    Genetic heterogeneity and mutational signature in Chinese Epstein-Barr virus-positive diffuse large B-cell lymphoma.
    PLoS One. 2018;13:e0201546.
    PubMed     Text format     Abstract available


  33. HOLLANDER P, Amini RM, Ginman B, Molin D, et al
    Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma.
    PLoS One. 2018;13:e0204870.
    PubMed     Text format     Abstract available


  34. BRESIN A, Ragone G, Cristofoletti C, Arcelli D, et al
    T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1.
    PLoS One. 2018;13:e0204775.
    PubMed     Text format     Abstract available


  35. DA ROS S, Aresu L, Ferraresso S, Zorzan E, et al
    Validation of epigenetic mechanisms regulating gene expression in canine B-cell lymphoma: An in vitro and in vivo approach.
    PLoS One. 2018;13:e0208709.
    PubMed     Text format     Abstract available


  36. MANSO R, Martinez-Magunacelaya N, Erana-Tomas I, Monsalvez V, et al
    Mycosis fungoides progression could be regulated by microRNAs.
    PLoS One. 2018;13:e0198477.
    PubMed     Text format     Abstract available


  37. DIAS JNR, Andre AS, Aguiar SI, Ministro J, et al
    Establishment of a bioluminescent canine B-cell lymphoma xenograft model for monitoring tumor progression and treatment response in preclinical studies.
    PLoS One. 2018;13:e0208147.
    PubMed     Text format     Abstract available


  38. YAN LX, Liu YH, Luo DL, Zhang F, et al
    Correction: MYC Expression in Concert With BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified.
    PLoS One. 2018;13:e0210027.
    PubMed     Text format     Abstract available


  39. CRAIG JW, Mina MJ, Crombie JL, LaCasce AS, et al
    Assessment of CD52 expression in "double-hit" and "double-expressor" lymphomas: Implications for clinical trial eligibility.
    PLoS One. 2018;13:e0199708.
    PubMed     Text format     Abstract available


  40. ANNIBALI O, Piccioni L, Tomarchio V, Circhetta E, et al
    Impact of IFN lambda 3/4 single nucleotide polymorphisms on the cytomegalovirus reactivation in autologous stem cell transplant patients.
    PLoS One. 2018;13:e0200221.
    PubMed     Text format     Abstract available


  41. VILLANUEVA PJ, Martinez A, Baca ST, DeJesus RE, et al
    Pyronaridine exerts potent cytotoxicity on human breast and hematological cancer cells through induction of apoptosis.
    PLoS One. 2018;13:e0206467.
    PubMed     Text format     Abstract available


  42. NAGEL S, MacLeod RAF, Meyer C, Kaufmann M, et al
    NKL homeobox gene activities in B-cell development and lymphomas.
    PLoS One. 2018;13:e0205537.
    PubMed     Text format     Abstract available


    January 2017
  43. FLETCHER LB, Veenstra RN, Loo EY, Hwang AE, et al
    HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patients.
    PLoS One. 2017;12:e0174457.
    PubMed     Text format     Abstract available


  44. ZHANG Y, Zhang R, Ding X, Peng B, et al
    FNC efficiently inhibits mantle cell lymphoma growth.
    PLoS One. 2017;12:e0174112.
    PubMed     Text format     Abstract available


  45. ZHOU X, Ma T, Zhang Y, Zhou N, et al
    Rituximab maintenance therapy for patients with diffuse large B-cell lymphoma: A meta-analysis.
    PLoS One. 2017;12:e0174648.
    PubMed     Text format     Abstract available


  46. YE X, Torabi M, Lix LM, Mahmud SM, et al
    Time and spatial trends in lymphoid leukemia and lymphoma incidence and survival among children and adolescents in Manitoba, Canada: 1984-2013.
    PLoS One. 2017;12:e0175701.
    PubMed     Text format     Abstract available


  47. WANG J, Zhou X, Liu Y, Li Z, et al
    Prognostic significance of neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma: A meta-analysis.
    PLoS One. 2017;12:e0176008.
    PubMed     Text format     Abstract available


  48. PROVENCIO M, Sabin P, Gomez-Codina J, Torrente M, et al
    Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry.
    PLoS One. 2017;12:e0177204.
    PubMed     Text format     Abstract available


  49. YAMAZAKI H, Lai YC, Tateno M, Setoguchi A, et al
    Hypoxia-activated prodrug TH-302 decreased survival rate of canine lymphoma cells under hypoxic condition.
    PLoS One. 2017;12:e0177305.
    PubMed     Text format     Abstract available


  50. BOYE P, Serres F, Marescaux L, Hordeaux J, et al
    Dose escalation study to evaluate safety, tolerability and efficacy of intravenous etoposide phosphate administration in 27 dogs with multicentric lymphoma.
    PLoS One. 2017;12:e0177486.
    PubMed     Text format     Abstract available


  51. RENGSTL B, Kim S, Doring C, Weiser C, et al
    Small and big Hodgkin-Reed-Sternberg cells of Hodgkin lymphoma cell lines L-428 and L-1236 lack consistent differences in gene expression profiles and are capable to reconstitute each other.
    PLoS One. 2017;12:e0177378.
    PubMed     Text format     Abstract available


  52. MONDEJAR R, Perez C, Onaindia A, Martinez N, et al
    Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell lines.
    PLoS One. 2017;12:e0177524.
    PubMed     Text format     Abstract available


  53. YUAN T, Zhang F, Yao QM, Liu YX, et al
    Weekly versus biweekly bortezomib given in patients with indolent non-Hodgkin lymphoma: A meta-analysis.
    PLoS One. 2017;12:e0177950.
    PubMed     Text format     Abstract available


  54. GARCIA-RECIO M, Cladera A, Bento L, Dominguez J, et al
    Analysis of the role of intratecal liposomal cytarabine in the prophylaxis and treatment of central nervous system lymphomatosis: The Balearic Lymphoma Group experience.
    PLoS One. 2017;12:e0179595.
    PubMed     Text format     Abstract available


  55. JIANG XN, Yu BH, Wang WG, Zhou XY, et al
    Anaplastic lymphoma kinase-positive large B-cell lymphoma: Clinico-pathological study of 17 cases with review of literature.
    PLoS One. 2017;12:e0178416.
    PubMed     Text format     Abstract available


  56. LIU Z, Li S, Liu Y, Guo W, et al
    PD1 is highly expressed in diffuse large B-cell lymphoma with hepatitis B virus infection.
    PLoS One. 2017;12:e0180390.
    PubMed     Text format     Abstract available


  57. DI NAPOLI A, Pepe G, Giarnieri E, Cippitelli C, et al
    Cytological diagnostic features of late breast implant seromas: From reactive to anaplastic large cell lymphoma.
    PLoS One. 2017;12:e0181097.
    PubMed     Text format     Abstract available


  58. MCKENZIE LM, Allshouse WB, Byers TE, Bedrick EJ, et al
    Childhood hematologic cancer and residential proximity to oil and gas development.
    PLoS One. 2017;12:e0170423.
    PubMed     Text format     Abstract available


  59. GANTUZ M, Lorenzetti MA, Chabay PA, Preciado MV, et al
    A novel recombinant variant of latent membrane protein 1 from Epstein Barr virus in Argentina denotes phylogeographical association.
    PLoS One. 2017;12:e0174221.
    PubMed     Text format     Abstract available


  60. QING Y, Gerson SL
    Mismatch repair deficient hematopoietic stem cells are preleukemic stem cells.
    PLoS One. 2017;12:e0182175.
    PubMed     Text format     Abstract available


  61. XU P, Liu X, Ouyang J, Chen B, et al
    TP53 mutation predicts the poor prognosis of non-Hodgkin lymphomas: Evidence from a meta-analysis.
    PLoS One. 2017;12:e0174809.
    PubMed     Text format     Abstract available


  62. TAKADA H, Imadome KI, Shibayama H, Yoshimori M, et al
    EBV induces persistent NF-kappaB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells.
    PLoS One. 2017;12:e0174136.
    PubMed     Text format     Abstract available


  63. KIVINIEMI V, Korhonen V, Kortelainen J, Rytky S, et al
    Real-time monitoring of human blood-brain barrier disruption.
    PLoS One. 2017;12:e0174072.
    PubMed     Text format     Abstract available


  64. GOUDEY B, Abraham G, Kikianty E, Wang Q, et al
    Interactions within the MHC contribute to the genetic architecture of celiac disease.
    PLoS One. 2017;12:e0172826.
    PubMed     Text format     Abstract available


  65. GROS A, Laharanne E, Vergier M, Prochazkova-Carlotti M, et al
    TP53 alterations in primary and secondary Sezary syndrome: A diagnostic tool for the assessment of malignancy in patients with erythroderma.
    PLoS One. 2017;12:e0173171.
    PubMed     Text format     Abstract available


  66. AJORLOO F, Vaezi M, Saadat A, Safaee SR, et al
    A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma.
    PLoS One. 2017;12:e0183969.
    PubMed     Text format     Abstract available


  67. HAYES DA, Kunde DA, Taylor RL, Pyecroft SB, et al
    ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1).
    PLoS One. 2017;12:e0177919.
    PubMed     Text format     Abstract available


  68. KOSMIDIS P, Bonzheim I, Dufke C, Colak S, et al
    Next generation sequencing of the clonal IGH rearrangement detects ongoing mutations and interfollicular trafficking in in situ follicular neoplasia.
    PLoS One. 2017;12:e0178503.
    PubMed     Text format     Abstract available


  69. ISAEVSKA E, Manasievska M, Alessi D, Mosso ML, et al
    Cancer incidence rates and trends among children and adolescents in Piedmont, 1967-2011.
    PLoS One. 2017;12:e0181805.
    PubMed     Text format     Abstract available


  70. SZABO SM, Hirji I, Johnston KM, Juarez-Garcia A, et al
    Treatment patterns and costs of care for patients with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin in the United States: A retrospective cohort study.
    PLoS One. 2017;12:e0180261.
    PubMed     Text format     Abstract available


  71. UCHIHARA Y, Ueda F, Tago K, Nakazawa Y, et al
    Alpha-tocopherol attenuates the anti-tumor activity of crizotinib against cells transformed by NPM-ALK.
    PLoS One. 2017;12:e0183003.
    PubMed     Text format     Abstract available


  72. PERSOON S, ChinAPaw MJM, Buffart LM, Liu RDK, et al
    Randomized controlled trial on the effects of a supervised high intensity exercise program in patients with a hematologic malignancy treated with autologous stem cell transplantation: Results from the EXIST study.
    PLoS One. 2017;12:e0181313.
    PubMed     Text format     Abstract available


  73. WEI S, Perera MLW, Sakhtemani R, Bhagwat AS, et al
    A novel class of chemicals that react with abasic sites in DNA and specifically kill B cell cancers.
    PLoS One. 2017;12:e0185010.
    PubMed     Text format     Abstract available


  74. CITRIN R, Horowitz JP, Reilly AF, Li Y, et al
    Creation of a pediatric mature B-cell non-Hodgkin lymphoma cohort within the Pediatric Health Information System Database.
    PLoS One. 2017;12:e0186960.
    PubMed     Text format     Abstract available


  75. PEDERSEN MO, Gang AO, Brown P, Pedersen M, et al
    Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers.
    PLoS One. 2017;12:e0186983.
    PubMed     Text format     Abstract available


  76. JORDI M, Marty J, Mordasini V, Lunemann A, et al
    IRAK4 is essential for TLR9-induced suppression of Epstein-Barr virus BZLF1 transcription in Akata Burkitt's lymphoma cells.
    PLoS One. 2017;12:e0186614.
    PubMed     Text format     Abstract available


  77. CINGOLANI A, Cozzi Lepri A, Teofili L, Galli L, et al
    Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population.
    PLoS One. 2017;12:e0186549.
    PubMed     Text format     Abstract available


  78. LIN GHY, Chai V, Lee V, Dodge K, et al
    TTI-621 (SIRPalphaFc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets.
    PLoS One. 2017;12:e0187262.
    PubMed     Text format     Abstract available


  79. HAMMERSEN F, Lewin P, Gebauer J, Kreitschmann-Andermahr I, et al
    Sleep quality and health-related quality of life among long-term survivors of (non-) Hodgkin lymphoma in Germany.
    PLoS One. 2017;12:e0187673.
    PubMed     Text format     Abstract available


  80. KHARE D, Goldschmidt N, Bardugo A, Gur-Wahnon D, et al
    Plasma microRNA profiling: Exploring better biomarkers for lymphoma surveillance.
    PLoS One. 2017;12:e0187722.
    PubMed     Text format     Abstract available


  81. TAUROZZI AJ, Beekharry R, Wantoch M, Labarthe MC, et al
    Spontaneous development of Epstein-Barr Virus associated human lymphomas in a prostate cancer xenograft program.
    PLoS One. 2017;12:e0188228.
    PubMed     Text format     Abstract available


    January 2016
  82. CANIONI D, Michot JM, Rabiega P, Molina TJ, et al
    In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas.
    PLoS One. 2016;11:e0156384.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: